Ajax-Loading

Daiichi Sankyo Co. Ltd. - Research and Development

Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Research-and-Development" stands at 441.24 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.

Daiichi Sankyo Co. Ltd.'s first quarter result of 105.95 Billion JPY for the item "Research and Development" represents a decrease of -20.55 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 105.95 Billion JPY for the item "Research and Development" represents an increase of 5.20 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 441.24 Billion JPY for the item "Research and Development" represents an increase of 1.20 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.50 percent compared to the value the year prior.
The 1 year change in percent is 13.50.
The 3 year change in percent is 56.97.
The 5 year change in percent is 115.09.
The 10 year change in percent is 123.20.

The Serie's long term average value is 249.74 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 76.68 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is +748.50%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.

Research and Development for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Research and Development905,699,262,464.00
LogoJohnson & Johnson - Research and Development486,508,953,600.00
LogoAbbVie Inc - Research and Development399,570,305,024.00
LogoRoche Holding AG - Research and Development317,433,206,677.55
LogoAstraZeneca PLC - Research and Development280,205,508,085.11